4.6 Article

Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Phage Therapy for Limb-threatening Prosthetic Knee Klebsiella pneumoniae Infection: Case Report and In Vitro Characterization of Anti-biofilm Activity

Edison J. Cano et al.

Summary: Phage therapy showed promising results in treating intractable biofilm-associated prosthetic knee infection and led to resolution of local symptoms and signs of infection, recovery of function, and absence of treatment-related adverse effects. Further studies are needed to assess the efficacy and safety of phage therapy for device-associated infections.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy

Olga Maria Rostkowska et al.

Summary: This article presents a case of a kidney transplant recipient who experienced recurrent urinary tract infections caused by multi-drug resistant ESBL-producing Klebsiella pneumoniae. Despite undergoing multiple treatment interventions, the patient fully recovered after nephrectomy and phage therapy. Further studies are needed to understand the role of phage therapy in controlling chronic UTIs in kidney transplant recipients.

TRANSPLANT INFECTIOUS DISEASE (2021)

Article Infectious Diseases

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

Lorenz Leitner et al.

Summary: This study aimed to determine the effectiveness of intravesical bacteriophage therapy in treating UTIs. Findings showed that bacteriophage therapy was non-inferior to standard antibiotic treatment, but not superior to placebo bladder irrigation in terms of efficacy or safety. The safety profile of bacteriophages appears to be favorable, suggesting potential for further large-scale clinical studies on their role in UTI treatment.

LANCET INFECTIOUS DISEASES (2021)

Article Virology

A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

David Lebeaux et al.

Summary: Phage therapy for A. xylosoxidans lung infection in a lung-transplanted patient showed good clinical tolerance, with gradual improvement in respiratory condition and successful discontinuation of oxygen therapy. Strain-specific qPCRs revealed a more complex dynamics of infection involving multiple strains.

VIRUSES-BASEL (2021)

Article Immunology

Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy

Jinhong Qin et al.

Summary: This case study illustrates the successful treatment of a patient with multidrug-resistant Klebsiella pneumoniae infections using a cocktail of bacteriophages and antibiotics. The strategy of combining phage therapy with antibiotic treatment proved effective in eradicating the infection. The presence of polyclonal co-infectious cells may pose a challenge in phage therapy, requiring a tailored approach based on individual patient characteristics.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Immunology

Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease

Xin Tan et al.

Summary: A case of an 88-year-old Chinese man with hospital-acquired pneumonia caused by carbapenem-resistant Acinetobacter baumannii was successfully treated with a personalized lytic pathogen-specific single-phage preparation nebulized continuously for 16 days, in combination with tigecycline and polymyxin E. The treatment was well tolerated and led to pathogen clearance and clinical improvement in lung function for the patient.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Immunology

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

Nannan Wu et al.

Summary: This study investigated the efficacy of phage therapy in treating secondary bacterial infections in COVID-19 patients. The results showed that phages were able to reduce the burden of CRAB infections, indicating their potential in responding to secondary outbreaks in COVID-19 patients.

EMERGING MICROBES & INFECTIONS (2021)

Review Infectious Diseases

Phage-Encoded Endolysins

Fatma Abdelrahman et al.

Summary: Endolysins have emerged as a potential alternative therapeutic approach against antibiotic-resistant bacterial infections, showing promising results in laboratory settings. However, further research is needed to understand their resistance, safety, and immunogenicity for in-vivo application.

ANTIBIOTICS-BASEL (2021)

Article Chemistry, Medicinal

Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy

James B. Doub et al.

Summary: This case presents a successful treatment strategy for a recalcitrant Staphylococcal epidermidis prosthetic knee infection using bacteriophage therapy, with additional benefits observed on the patient's pre-existing aplastic anemia condition.

PHARMACEUTICALS (2021)

Review Biochemical Research Methods

Bacteriophage endolysins - extending their application to tissues and the bloodstream

Mathias Schmelcher et al.

Summary: Endolysins, as a promising new class of antimicrobials, have shown effectiveness in various animal models against bacterial infections in different organs and tissues. However, challenges such as immunogenicity, circulation half-life, and specific targeting and penetration properties still need to be addressed for their systemic application.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Review Biochemical Research Methods

Application of bacteriophage-derived endolysins to combat streptococcal disease: current State and perspectives

Sara B. Linden et al.

Summary: The decline in new antibiotic candidates and the increase in antibiotic resistance have led to the development of alternative antimicrobials, such as bacteriophage-encoded endolysins. Current studies focus on the discovery, structure/function, engineering, immunogenicity, toxicity/safety, and efficacy of endolysins, with some already in human clinical trials. Streptococcal diseases primarily affect accessible mucous membranes, making them a promising target for protein therapeutics, such as targeted endolysin therapy.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Review Biochemical Research Methods

Targeting biofilms using phages and their enzymes

Joana Azeredo et al.

Summary: The complex biofilm architecture composed of EPS provides a protective shield for bacteria. Phages have developed strategies to overcome biofilm barriers and their enzymes can combat biofilms by degrading EPS. Combining phages or phage-borne enzymes with antibiotics can achieve antibiofilm performance.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Review Virology

The Advantages and Challenges of Using Endolysins in a Clinical Setting

Ellen Murray et al.

Summary: Antibiotic-resistant pathogens are on the rise, posing a growing problem. Traditional antibiotics are no longer effective, creating a need for new approaches. Bacteriophage-derived proteins, such as endolysins, have shown promise in effectively targeting and destroying bacterial cells, particularly Gram-positive bacteria. This has led to a renewed interest in endolysin therapy and its potential as a new antimicrobial therapy, despite some regulatory and logistical challenges.

VIRUSES-BASEL (2021)

Article Medicine, General & Internal

Case Report: Arthroscopic Debridement Antibiotics and Implant Retention With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Pseudomonas Aeruginosa Prosthetic Knee Infection

Tristan Ferry et al.

Summary: This case report demonstrates the successful use of phage therapy in controlling prosthetic knee infection in an 88-year-old male patient. The patient showed significant improvement under this treatment, suggesting the potential of phage therapy in the management of PJI.

FRONTIERS IN MEDICINE (2021)

Review Biotechnology & Applied Microbiology

Application of bacteriophages and endolysins in aquaculture as a biocontrol measure

Ramesh Nachimuthu et al.

Summary: Aquaculture, a major food source for half of the global population, is experiencing significant losses due to infectious diseases. Rising antibiotic resistance necessitates alternative therapeutic measures to sustain production. The use of bacteriophages as biocontrol agents shows promise in combating bacterial infections.

BIOLOGICAL CONTROL (2021)

Article Biochemistry & Molecular Biology

Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection

Rebekah M. Dedrick et al.

Summary: In a case study, it was found that bacteriophage therapy was effective in reducing the infectious burden of a refractory bacterial infection in an immunocompetent patient, but its efficacy was limited as the patient developed neutralizing antibodies against the phages after two months.

NATURE MEDICINE (2021)

Article Virology

Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy

Claudia Ramirez-Sanchez et al.

Summary: Successful joint replacement is a life-enhancing procedure with significant growth in the past decade. Prosthetic joint infection is a biofilm-based infection that can be difficult to treat, but recent interest in bacteriophage therapy has shown promise in treating these infections successfully.

VIRUSES-BASEL (2021)

Article Pharmacology & Pharmacy

Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments

Apurva Virmani Johri et al.

Summary: Chronic Bacterial Prostatitis is a long-lasting inflammatory condition primarily affecting men under 50, with limited effectiveness of antibiotic treatment and bacteriophage therapy emerging as a promising alternative. The use of lytic bacterial viruses has shown significant improvements in controlling chronic infections caused by antibiotic-resistant bacteria in the male pelvic region.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biotechnology & Applied Microbiology

Anti-phage serum antibody responses and the outcome of phage therapy

M. Lusiak-Szelachowska et al.

Summary: The study found that there was no correlation between serum anti-phage antibody levels and the outcome of phage therapy (PT) in patients with chronic sinusitis. Approximately 30% of patients with weak antibody responses still responded positively to PT, indicating that antibody levels may not be a determining factor in the effectiveness of the treatment.

FOLIA MICROBIOLOGICA (2021)

Review Biochemistry & Molecular Biology

Phage Therapy: The Pharmacology of Antibacterial Viruses

Katarzyna Danis-Wlodarczyk et al.

Summary: Pharmacology is divided into pharmacodynamics and pharmacokinetics, which respectively focus on the effects of drugs on the body and the effects of the body on drugs. Bacteriophages, viruses of bacteria used in phage therapy, have unique pharmacological aspects that can be understood through basic principles of their ecological interactions with bacteria.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)

Article Microbiology

Safety of bacteriophage therapy in severe Staphylococcus aureus infection

Aleksandra Petrovic Fabijan et al.

NATURE MICROBIOLOGY (2020)

Review Microbiology

Diversity and Function of Phage Encoded Depolymerases

Leandra E. Knecht et al.

FRONTIERS IN MICROBIOLOGY (2020)

Review Infectious Diseases

The forgotten tale of Brazilian phage therapy

Gabriel Magno de Freitas Almeida et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins

H. Gerstmans et al.

SCIENCE ADVANCES (2020)

Article Medicine, Research & Experimental

Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

Vance G. Fowler et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Infectious Diseases

Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection

James B. Doub et al.

ANTIBIOTICS-BASEL (2020)

Article Infectious Diseases

Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery

Evgenii Rubalskii et al.

ANTIBIOTICS-BASEL (2020)

Editorial Material Multidisciplinary Sciences

Bacteria-eating viruses could provide a route to stability in cystic fibrosis

Elizabeth Svoboda

NATURE (2020)

Review Microbiology

Advanced engineering of third-generation lysins and formulation strategies for clinical applications

Vincent De Maesschalck et al.

CRITICAL REVIEWS IN MICROBIOLOGY (2020)

Review Pharmacology & Pharmacy

Use of phage therapy to treat long-standing, persistent, or chronic bacterial infections

Stephen T. Abedon

ADVANCED DRUG DELIVERY REVIEWS (2019)

Article Nutrition & Dietetics

Bacteriophage for Gastrointestinal Health (PHAGE) Study: Evaluating the Safety and Tolerability of Supplemental Bacteriophage Consumption

Melinda Gindin et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2019)

Article Biochemistry & Molecular Biology

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

Rebekah M. Dedrick et al.

NATURE MEDICINE (2019)

Review Virology

Current State of Compassionate Phage Therapy

Shawna McCallin et al.

VIRUSES-BASEL (2019)

Article Dermatology

Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study

Pooja Gupta et al.

INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2019)

Article Surgery

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients

Saima Aslam et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2019)

Letter Medicine, General & Internal

Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus

Timothy Gilbey et al.

MEDICAL JOURNAL OF AUSTRALIA (2019)

Article Otorhinolaryngology

Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus

Mian Li Ooi et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2019)

Letter Critical Care Medicine

Bacteriophage Therapy of Ventilator-associated Pneumonia and Empyema Caused by Pseudomonas aeruginosa

Susan Maddocks et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Letter Cardiac & Cardiovascular Systems

Novel bacteriophage therapy for treatment of left ventricular assist device infection

Saima Aslam et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2019)

Article Microbiology

Sourcing phages for compassionate use

Jessica C. Sacher et al.

MICROBIOLOGY AUSTRALIA (2019)

Article Infectious Diseases

Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy

C. Duplessis et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2018)

Review Biotechnology & Applied Microbiology

Synthetic biology of modular endolysins

Hans Gerstmans et al.

BIOTECHNOLOGY ADVANCES (2018)

Article Immunology

Phage Therapy for a MultidrugResistant Acinetobacter baumannii Craniectomy Site Infection

Stephanie LaVergne et al.

OPEN FORUM INFECTIOUS DISEASES (2018)

Article Microbiology

Adapted Bacteriophages for Treating Urinary Tract Infections

Aleksandre Ujmajuridze et al.

FRONTIERS IN MICROBIOLOGY (2018)

Article Infectious Diseases

Resolving Digital Staphylococcal Osteomyelitis Using Bacteriophage-A Case Report

Randolph Fish et al.

ANTIBIOTICS-BASEL (2018)

Article Evolutionary Biology

Phage treatment of an aortic graft infected with & IT;Pseudomonas aeruginosa & IT;

Benjamin K. Chan et al.

EVOLUTION MEDICINE AND PUBLIC HEALTH (2018)

Article Microbiology

Antiphage activity of sera during phage therapy in relation to its outcome

Marzanna Lusiak-Szelachowska et al.

FUTURE MICROBIOLOGY (2017)

Article Microbiology

Bacteriophage Clinical Use as Antibacterial Drugs: Utility and Precedent

Stephen T. Abedon

MICROBIOLOGY SPECTRUM (2017)

Article Microbiology

Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128

Nethravathi Poonacha et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Article Medicine, General & Internal

Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome

Pikria Zhvania et al.

FRONTIERS IN MEDICINE (2017)

Review Biotechnology & Applied Microbiology

Bacteriophage-encoded depolymerases: their diversity and biotechnological applications

Diana P. Pires et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)

Article Dermatology

Bacteriophage treatment of intransigent diabetic toe ulcers: a case series

R. Fish et al.

JOURNAL OF WOUND CARE (2016)

Editorial Material Virology

Experience of the Eliava Institute in bacteriophage therapy

Mzia Kutateladze

VIROLOGICA SINICA (2015)

Article Ophthalmology

Corneal Infection Therapy with Topical Bacteriophage Administration

Ali Fadlallah et al.

OPEN OPHTHALMOLOGY JOURNAL (2015)

Article Immunology

Phage Neutralization by Sera of Patients Receiving Phage Therapy

Marzanna Lusiak-Szelachowska et al.

VIRAL IMMUNOLOGY (2014)

Article Microbiology

Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection

A. Khawaldeh et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2011)

Article Biotechnology & Applied Microbiology

Evaluation of lytic activity of staphylococcal bacteriophage Sb-1 against freshly isolated clinical pathogens

Leila Kvachadze et al.

MICROBIAL BIOTECHNOLOGY (2011)

Review Biochemistry & Molecular Biology

Phage Therapy in Clinical Practice: Treatment of Human Infections

Elizabeth Kutter et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)

Review Immunology

The perspectives of the application of phage therapy in chronic bacterial prostatitis

Slawomir Letkiewicz et al.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2010)

Article Biotechnology & Applied Microbiology

Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis - case report

S. Letkiewicz et al.

FOLIA MICROBIOLOGICA (2009)

Article Infectious Diseases

Phage therapy experience at the Eliava Institute

M. Kutateladze et al.

MEDECINE ET MALADIES INFECTIEUSES (2008)

Article Immunology

Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man

B Weber-Dabrowska et al.

TRANSPLANTATION PROCEEDINGS (2003)

Review Microbiology

Bacteriophage therapy

WC Summers

ANNUAL REVIEW OF MICROBIOLOGY (2001)